Scientific reports

Dapagliflozin reduces kidney damage from cisplatin in rats by affecting cell stress and survival signals

Updated

Abstract

Dapagliflozin (DPG) significantly reduced renal damage in rats subjected to cisplatin-induced nephrotoxicity.

  • DPG administration lowered levels of injury markers such as NGAL and KIM-1.
  • Treatment with DPG decreased oxidative stress indicators, including malondialdehyde (MDA) and nitric oxide (NO), while increasing glutathione (GSH) levels.
  • DPG inhibited the expression of pro-inflammatory and apoptotic factors, such as NF-κB, TNF-α, IL-6, and Bax, while promoting BCL2 expression.
  • Caspase-3 activity, associated with apoptosis, was reduced in the presence of DPG.
  • DPG enhanced mitophagy, indicated by increased levels of PINK1, Parkin, and the LC3II/LC3I ratio, and decreased TIMM23, TOMM20, and p62 levels.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declarations. Competing interests: The authors declare no competing interests. Ethical approval: The animal experiments were certified by the Ethics Committee of the British University in Egypt (EX-2318), in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free